Lecturer in Law
Brian Richmand’s career in Private Equity spans over 30 years and includes experience as an investor, attorney, and educator in leveraged buyouts, recapitalizations, growth equity, and venture capital transactions.
Brian began his private equity career in 1979 as an attorney at the national law firm of Kirkland & Ellis, where he founded and headed the Private Equity Practice Group at the firm’s Washington, D.C. office. During his tenure at K&E, Brian was rose to Share Partner and built a national practice representing pre-eminent private equity funds.
In 1993, Brian left the practice of law to become a General Partner at the private equity firm Chase Capital Partners (now CCMP Capital Advisors). While at Chase Capital, Brian served on the Investment Committee responsible for investing over $5 billion and personally led investment teams investing over $300 million in equity capital.
In 2000, Brian left his full-time affiliation with Chase Capital in order to devote his time his personal investment portfolio, continued portfolio company management on behalf of Chase Capital, and medical research focusing on the immunological causes of pediatric neuropsychiatric disorders.
In 2013, Brian was appointed to the adjunct faculty at America University’s Washington College of Law, where he teaches a clinical seminar in structuring private equity transactions. Brian is also a frequent guest lecturer on Private Equity/M&A topics at the University of Maryland’s Robert H. Smith School of Business.
Although Brian’s formal training has been largely in law and finance, Brian is most proud of his scientific work in a pediatric autoimmune disorder commonly known as PANDAS. Brian has been instrumental in designing and organizing 5 completed and ongoing research studies at Yale Medical School, Oklahoma University Health Sciences Center, and Schneider Children’s Medical Center (Tel Aviv, Israel). Brian has also authored and co-authorized multiple papers published in peer-reviewed medical journals.
Brian received a B.S. from The Wharton School of Finance and Commerce in 1976 and his J.D. from Stanford Law School in 1979. More recently, Brian has pursued post-baccalaureate studies in immunology and other life sciences.